Legend Biotech Corporation (LEGN) Financials

LEGN Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 1.8 billion 589.9 million
2023-09-30 1.8 billion 499.7 million
2023-06-30 1.9 billion 523.6 million
2023-03-31 1.2 billion 556.2 million

LEGN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -118.7 million 12.6 million
2023-09-30 -66.3 million 12.4 million
2023-06-30 -106.1 million ?
2023-03-31 -141.1 million ?

LEGN Net Income

No data available :(

LEGN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 1.3 billion - 47.3 million
2023-09-30 1.4 billion - 44.6 million
2023-06-30 1.5 billion - 48.0 million
2023-03-31 850.1 million - 48.9 million

LEGN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 181.9 million
2023-09-30 348.3 million
2023-06-30 175.5 million
2023-03-31 165.2 million

LEGN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 25.4 million 105.7 million 62.4 million -
2023-09-30 5.5 million 95.9 million 28.1 million 21.1 million
2023-06-30 10.4 million 95.8 million 27.8 million 21.4 million
2023-03-31 10.4 million 84.9 million 22.2 million 18.0 million

LEGN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 79.5 million 37.8 million
2023-09-30 96.0 million 43.5 million
2023-06-30 73.3 million 32.7 million
2023-03-31 36.3 million 35.6 million

LEGN

Price: $45.99

52 week price:
43.74
77.32

Earnings Per Share: -2.94 USD

P/E Ratio: -20.60

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 302700

Market Capitalization: 9.6 billion

Links: